Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells

Virology

Volumn 413, Issue 1, 2011, Pages 1-11

  Myoung, Jinjong ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abortive infection; Human herpesvirus; Human lymphoid aggregate culture; Infectious virus particle; KSHV; Lymphoid infection; Replication

Indexed keywords

CD19 ANTIGEN; GREEN FLUORESCENT PROTEIN; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN HERPESVIRUS 8; LYMPHOCYTE TRANSFORMATION; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TONSIL; VIRUS ENTRY; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOCYTES; PALATINE TONSIL; T-LYMPHOCYTES; VERO CELLS; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 79953104368     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.12.036     Document Type: Article

References (56)

1. Altmann M., Pich D., Ruiss R., Wang J., Sugden B., Hammerschmidt W. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc. Natl. Acad. Sci. USA 2006, 103(38):14188-14193.
2. Aman P., Gordon J., Lewin N., Nordstrom M., Ehlin-Henriksson B., Klein G., Carstensson A. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations. J. Immunol. 1985, 135(4):2362-2367.
3. Ambroziak J.A., Blackbourn D.J., Herndier B.G., Glogau R.G., Gullett J.H., McDonald A.R., Lennette E.T., Levy J.A. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995, 268(5210):582-583.
4. Babcock G.J., Thorley-Lawson D.A. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc. Natl. Acad. Sci. USA 2000, 97(22):12250-12255.
5. Bechtel J.T., Liang Y., Hvidding J., Ganem D. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 2003, 77(11):6474-6481.
6. Benyesh-Melnick M., Probstmeyer F., McCombs R., Brunschwig J.P., Vonka V. Correlation between infectivity and physical virus particles in human cytomegalovirus. J. Bacteriol. 1966, 92(5):1555-1561.
7. Blackbourn D.J., Lennette E., Klencke B., Moses A., Chandran B., Weinstein M., Glogau R.G., Witte M.H., Way D.L., Kutzkey T., Herndier B., Levy J.A. The restricted cellular host range of human herpesvirus 8. AIDS 2000, 14(9):1123-1133.
8. Blasig C., Zietz C., Haar B., Neipel F., Esser S., Brockmeyer N.H., Tschachler E., Colombini S., Ensoli B., Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 1997, 71(10):7963-7968.
9. Boshoff C., Schulz T.F., Kennedy M.M., Graham A.K., Fisher C., Thomas A., McGee J.O., Weiss R.A., O'Leary J.J. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1995, 1(12):1274-1278.
10. Boshoff C., Whitby D., Hatziioannou T., Fisher C., van der Walt J., Hatzakis A., Weiss R., Schulz T. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995, 345(8956):1043-1044.
11. Carbone A., Gloghini A. KSHV/HHV8-associated lymphomas. Br. J. Haematol. 2008, 140(1):13-24.
12. Cerimele F., Curreli F., Ely S., Friedman-Kien A.E., Cesarman E., Flore O. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J. Virol. 2001, 75(5):2435-2443.
13. Cesarman E., Moore P.S., Rao P.H., Inghirami G., Knowles D.M., Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86(7):2708-2714.
14. Cesarman E., Nador R.G., Aozasa K., Delsol G., Said J.W., Knowles D.M. Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am. J. Pathol. 1996, 149(1):53-57.
15. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266(5192):1865-1869.
16. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435(7038):108-114.
17. Chuck S., Grant R.M., Katongole-Mbidde E., Conant M., Ganem D. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J. Infect. Dis. 1996, 173(1):248-251.
18. Coupland S.E., Charlotte F., Mansour G., Maloum K., Hummel M., Stein H. HHV-8-associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man. Am. J. Surg. Pathol. 2005, 29(5):647-652.
19. Dargan D.J., Patel A.H., Subak-Sharpe J.H. PREPs: herpes simplex virus type 1-specific particles produced by infected cells when viral DNA replication is blocked. J. Virol. 1995, 69(8):4924-4932.
20. Dupin N., Fisher C., Kellam P., Ariad S., Tulliez M., Franck N., van Marck E., Salmon D., Gorin I., Escande J.P., Weiss R.A., Alitalo K., Boshoff C. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl Acad. Sci. USA 1999, 96(8):4546-4551.
21. Eckstein D.A., Penn M.L., Korin Y.D., Scripture-Adams D.D., Zack J.A., Kreisberg J.F., Roederer M., Sherman M.P., Chin P.S., Goldsmith M.A. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity 2001, 15(4):671-682.
22. Ensoli B., Sturzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 1998, 9(1):63-83.
23. Ensoli B., Nakamura S., Salahuddin S.Z., Biberfeld P., Larsson L., Beaver B., Wong-Staal F., Gallo R.C. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989, 243(4888):223-226.
24. Ensoli B., Markham P., Kao V., Barillari G., Fiorelli V., Gendelman R., Raffeld M., Zon G., Gallo R.C. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J. Clin. Invest. 1994, 94(5):1736-1746.
25. Ensoli B., Sgadari C., Barillari G., Sirianni M.C., Sturzl M., Monini P. Biology of Kaposi's sarcoma. Eur. J. Cancer 2001, 37(10):1251-1269.
26. Faumont N., Durand-Panteix S., Schlee M., Gromminger S., Schuhmacher M., Holzel M., Laux G., Mailhammer R., Rosenwald A., Staudt L.M., Bornkamm G.W., Feuillard J. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. J. Virol. 2009, 83(10):5014-5027.
27. Fiorelli V., Gendelman R., Samaniego F., Markham P.D., Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest. 1995, 95(4):1723-1734.
28. Gambassi G., Semeraro R., Suma V., Sebastio A., Incalzi R.A. Aggressive behavior of classical Kaposi's sarcoma and coexistence with angiosarcoma. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60(4):520-523.
29. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 2006, 1:273-296.
30. Glushakova S., Baibakov B., Margolis L.B., Zimmerberg J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat. Med. 1995, 1(12):1320-1322.
31. Grivel J.C., Santoro F., Chen S., Faga G., Malnati M.S., Ito Y., Margolis L., Lusso P. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J. Virol. 2003, 77(15):8280-8289.
32. Grossmann C., Ganem D. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology 2008, 375(1):94-102.
33. Harrington W.J., Bagasra O., Sosa C.E., Bobroski L.E., Baum M., Wen X.L., Cabral L., Byrne G.E., Pomerantz R.J., Wood C. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J. Infect. Dis. 1996, 174(5):1101-1105.
34. Herndier B., Ganem D. The biology of Kaposi's sarcoma. Cancer Treat. Res. 2001, 104:89-126.
35. Inoue N., Winter J., Lal R.B., Offermann M.K., Koyano S. Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line. J. Virol. 2003, 77(14):8147-8152.
36. Kreisberg J.F., Yonemoto W., Greene W.C. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 2006, 203(4):865-870.
37. Lagunoff M., Bechtel J., Venetsanakos E., Roy A.M., Abbey N., Herndier B., McMahon M., Ganem D. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 2002, 76(5):2440-2448.
38. Lechapt-Zalcman E., Challine D., Delfau-Larue M.H., Haioun C., Desvaux D., Gaulard P. Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man. Arch. Pathol. Lab. Med. 2001, 125(9):1246-1248.
39. Lospalluti M., Mastrolonardo M., Loconsole F., Conte A., Rantuccio F. Classical Kaposi's sarcoma: a survey of 163 cases observed in Bari, south Italy. Dermatology 1995, 191(2):104-108.
40. Martin D., Gutkind J.S. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene 2008, 27(Suppl. 2):S31-S42.
41. Mesri E.A., Cesarman E., Arvanitakis L., Rafii S., Moore M.A., Posnett D.N., Knowles D.M., Asch A.S. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med. 1996, 183(5):2385-2390.
42. Nador R.G., Cesarman E., Knowles D.M., Said J.W. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N. Engl. J. Med. 1995, 333(14):943.
43. Penn M.L., Grivel J.C., Schramm B., Goldsmith M.A., Margolis L. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc. Natl. Acad. Sci. USA 1999, 96(2):663-668.
44. Rappocciolo G., Hensler H.R., Jais M., Reinhart T.A., Pegu A., Jenkins F.J., Rinaldo C.R. Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J. Virol. 2008, 82(10):4793-4806.
45. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 1996, 2(3):342-346.
46. Renne R., Blackbourn D., Whitby D., Levy J., Ganem D. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 1998, 72(6):5182-5188.
47. Roush K.S., Domiati-Saad R.K., Margraf L.R., Krisher K., Scheuermann R.H., Rogers B.B., Dawson D.B. Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am. J. Clin. Pathol. 2001, 116(5):648-654.
48. Said J.W., Shintaku I.P., Asou H., deVos S., Baker J., Hanson G., Cesarman E., Nador R., Koeffler H.P. Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Arch. Pathol. Lab. Med. 1999, 123(3):257-260.
49. Sirianni M.C., Vincenzi L., Topino S., Scala E., Angeloni A., Gonnella R., Uccini S., Faggioni A. Human herpesvirus 8 DNA sequences in CD8+ T cells. J. Infect. Dis. 1997, 176(2):541.
50. Strowig T., Brilot F., Arrey F., Bougras G., Thomas D., Muller W.A., Munz C. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma. PLoS Pathog. 2008, 4(2):e27.
51. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001, 1(1):75-82.
52. Thorley-Lawson D.A., Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 2004, 350(13):1328-1337.
53. Vieira J., O'Hearn P.M. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 2004, 325(2):225-240.
54. Vieira J., O'Hearn P., Kimball L., Chandran B., Corey L. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J. Virol. 2001, 75(3):1378-1386.
55. Wu W., Vieira J., Fiore N., Banerjee P., Sieburg M., Rochford R., Harrington W., Feuer G. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 2006, 108(1):141-151.
56. Zhou F.C., Zhang Y.J., Deng J.H., Wang X.P., Pan H.Y., Hettler E., Gao S.J. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 2002, 76(12):6185-6196.